financial guidance
Agilent Q4 Revenues Rise 12 Percent
Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter.
Sophia Genetics Q3 Revenues Increase 44 Percent
Net loss for the bioinformatics firm, which went public in July, more than doubled year over year during the third quarter to $10.2 million.
Veracyte Q3 Revenues Nearly Double
Total revenues grew to $60.4 million and testing volume for its genomic tests were up 79 percent year over year.
Dermtech Q3 Revenues Rise 122 Percent
The company said it recorded a 75 percent increase in billable sample volume during the quarter, and a 140 percent increase in assay revenues.
Fluidigm Q3 Revenues Drop 29 Percent on Supply Chain Issues, Waning COVID-19 Testing
The company also lowered its full-year financial guidance and said its board of directors is undertaking a strategic review to maximize shareholder value.
Nov 8, 2021
Castle Biosciences Q3 Revenues Rise 54 Percent
Nov 4, 2021
Natera Q3 Revenues Grow 61 Percent
Nov 4, 2021
NeoGenomics Q3 Revenues Drop 3 Percent
Nov 2, 2021
Exact Sciences Q3 Revenues Rise 12 Percent
Oct 27, 2021
Thermo Fisher Scientific Q3 Revenues up 9 Percent
Aug 17, 2021
Agilent Technologies Q3 Revenues Rise 26 Percent
Aug 9, 2021